These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1614034)

  • 1. Experimental model of lead nephropathy. I. Continuous high-dose lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH; Alinovi R; Bergamaschi E; Mutti A; Rosen VJ
    Kidney Int; 1992 May; 41(5):1192-203. PubMed ID: 1614034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of lead nephropathy. III. Continuous low-level lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH
    Arch Environ Health; 1993; 48(4):271-8. PubMed ID: 8357279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental model of lead nephropathy. II. Effect of removal from lead exposure and chelation treatment with dimercaptosuccinic acid (DMSA).
    Khalil-Manesh F; Gonick HC; Cohen A; Bergamaschi E; Mutti A
    Environ Res; 1992 Jun; 58(1):35-54. PubMed ID: 1317791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies.
    Brzóska MM; Kamiński M; Supernak-Bobko D; Zwierz K; Moniuszko-Jakoniuk J
    Arch Toxicol; 2003 Jun; 77(6):344-52. PubMed ID: 12799774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamics in rats with cadmium-induced nephropathy.
    Uriu K; Kaizu K; Komine N; Ikeda M; Qie YL; Hashimoto O; Matsuoka A; Eto S
    Toxicol Appl Pharmacol; 1998 May; 150(1):76-85. PubMed ID: 9630455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental model of lead nephropathy. IV. Correlation between renal functional changes and hematological indices of lead toxicity.
    Khalil-Manesh F; Tartaglia-Erler J; Gonick HC
    J Trace Elem Electrolytes Health Dis; 1994 Mar; 8(1):13-9. PubMed ID: 7804024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities.
    Sivaprasad TR; Malarkodi SP; Varalakshmi P
    Chem Biol Interact; 2004 Apr; 147(3):259-71. PubMed ID: 15135082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C; Velciov S; Kaycsa A; Gluhovschi G; Petrica L; Marian R; Bozdog G; Gadalean F; Bob F; Cioca D; Vernic C
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
    Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
    Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
    Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat.
    Josepovitz C; Levine R; Lane B; Kaloyanides GJ
    Lab Invest; 1985 Apr; 52(4):375-86. PubMed ID: 2858601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
    Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
    Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal injury induced by long-term administration of cyclosporin A to rats.
    Bertani T; Perico N; Abbate M; Battaglia C; Remuzzi G
    Am J Pathol; 1987 Jun; 127(3):569-79. PubMed ID: 3591904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related proximal tubular dysfunction in male rats chronically exposed to lead.
    Vyskocil A; Pancl J; Tusl M; Ettlerova E; Semecky V; Kasparová L; Lauwerys R; Bernard A
    J Appl Toxicol; 1989 Dec; 9(6):395-9. PubMed ID: 2693512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary biomarkers in assessing the nephrotoxic potential of gentamicin in solitary kidney patients after 7 days of therapy.
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Ren Fail; 2014 May; 36(4):534-40. PubMed ID: 24456153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.